775 related articles for article (PubMed ID: 9738611)
1. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection.
Wells PS; Kovacs MJ; Bormanis J; Forgie MA; Goudie D; Morrow B; Kovacs J
Arch Intern Med; 1998 Sep; 158(16):1809-12. PubMed ID: 9738611
[TBL] [Abstract][Full Text] [Related]
2. Outpatient treatment of pulmonary embolism with dalteparin.
Kovacs MJ; Anderson D; Morrow B; Gray L; Touchie D; Wells PS
Thromb Haemost; 2000 Feb; 83(2):209-11. PubMed ID: 10739374
[TBL] [Abstract][Full Text] [Related]
3. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin.
Harrison L; McGinnis J; Crowther M; Ginsberg J; Hirsh J
Arch Intern Med; 1998 Oct; 158(18):2001-3. PubMed ID: 9778199
[TBL] [Abstract][Full Text] [Related]
4. Outpatient treatment of patients with deep-vein thrombosis or pulmonary embolism.
Wells PS
Curr Opin Pulm Med; 2001 Sep; 7(5):360-4. PubMed ID: 11584190
[TBL] [Abstract][Full Text] [Related]
5. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
[TBL] [Abstract][Full Text] [Related]
6. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
[TBL] [Abstract][Full Text] [Related]
8. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.
Decousus H; Leizorovicz A; Parent F; Page Y; Tardy B; Girard P; Laporte S; Faivre R; Charbonnier B; Barral FG; Huet Y; Simonneau G
N Engl J Med; 1998 Feb; 338(7):409-15. PubMed ID: 9459643
[TBL] [Abstract][Full Text] [Related]
9. Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients.
Siragusa S; Arcara C; Malato A; Anastasio R; Valerio MR; Fulfaro F; Lo Coco L; Grimaudo S; Bajardi G; Abbadessa V; Gebbia N
Ann Oncol; 2005 May; 16 Suppl 4():iv136-139. PubMed ID: 15923414
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism.
; Büller HR; Gent M; Gallus AS; Ginsberg J; Prins MH; Baildon R
N Engl J Med; 1997 Sep; 337(10):657-62. PubMed ID: 9280815
[TBL] [Abstract][Full Text] [Related]
11. Home treatment of deep vein thrombosis. An out-patient treatment model with once-daily injection of low-molecular-weight heparin (tinzaparin) in 555 patients.
Lapidus L; Börretzen J; Fahlén M; Thomsen HG; Hasselblom S; Larson L; Nordström H; Stigendal L; Waller L
Pathophysiol Haemost Thromb; 2002; 32(2):59-66. PubMed ID: 12214150
[TBL] [Abstract][Full Text] [Related]
12. Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis.
Dager WE; King JH; Branch JM; Chow SL; Ferrer RE; Pak S; Togioka PY; White RH
Ann Pharmacother; 2005; 39(7-8):1182-7. PubMed ID: 15956232
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism.
Wells PS; Anderson DR; Rodger MA; Forgie MA; Florack P; Touchie D; Morrow B; Gray L; O'Rourke K; Wells G; Kovacs J; Kovacs MJ
Arch Intern Med; 2005 Apr; 165(7):733-8. PubMed ID: 15824291
[TBL] [Abstract][Full Text] [Related]
14. Home treatment of deep vein thrombosis: a two-years experience of a single institution.
Grau E; Real E; Pastor E; Viciano V; Aguiló J
Haematologica; 1998 May; 83(5):438-41. PubMed ID: 9658729
[TBL] [Abstract][Full Text] [Related]
15. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
Belcaro G; Nicolaides AN; Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Barsotti A; Corsi M; Vasdekis S; Christopoulos D; Lennox A; Malouf M
Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
[TBL] [Abstract][Full Text] [Related]
16. Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting. Swedish Venous Thrombosis Dalteparin Trial Group.
Lindmarker P; Holmström M
J Intern Med; 1996 Dec; 240(6):395-401. PubMed ID: 9010387
[TBL] [Abstract][Full Text] [Related]
17. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
[TBL] [Abstract][Full Text] [Related]
18. Treatment of deep vein thrombosis in patients with pulmonary embolism: subgroup analysis on the efficacy and safety of certoparin vs. unfractionated heparin.
Riess H; Becker LK; Melzer N; Harenberg J
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):838-44. PubMed ID: 25004024
[TBL] [Abstract][Full Text] [Related]
19. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
[TBL] [Abstract][Full Text] [Related]
20. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]